Resources
Statement on the current state of development of the EHDS
The BioMed Alliance Task Force on Health Data submitted responses to the public consultations on the European Health Data Space (EHDS) launched by the European Commission.
On this occasion we also...
CORE-MD project: survey on education in regulatory affairs
As part of our work on the CORE-MD project we are running a short questionnaire on education in regulatory affairs. The questionnaire assesses what sort of training or education exists to inform healt...
New BioMed Alliance Statement: Open Access Initiatives must not create inequality
In a new statement published on 5 October, medical societies from the Open Access Transition Working Group of the BioMed Alliance highlight a series of concerns around Plan S. They also express their...
Reducing bureaucracy in clinical trials: now is the time!
Medical societies and patient advocates across disciplines call for urgent action to make clinical trials less bureaucratic and more patient-centered, efficient and cheaper.
To achieve this, stakehol...
Policy paper: Moving forward from drug-centered to patient-centered clinical research
BioMed Alliance members contributed to a White Paper initiated by EORTC on academic clinical research....
Open Access Transition Working Group
Description
The BioMed Alliance has created an Open Access Transition Working Group, which consists of representatives interested in publishing. They jointly discuss policies and initiatives related...
BioMed Alliance calls for progress on EU-level HTA
In a new statement published on 3 September, the BioMed Alliance calls on the German Council Presidency to guide Member States into adopting a position on the Regulation for Cooperation on Health Tech...
BioMed Alliance calls for rapid progress in IVDR implementation
The BioMed Alliance published a new statement calling for urgent action to ensure optimal implementation of the EU In Vitro Diagnostic devices regulation (IVDR). The statement calls on the European Co...
Statement calling to speed-up IVDR implementation
In July 2020, the BioMed Alliance published a statement calling for urgent action to ensure optimal implementation of the EU In Vitro Diagnostic devices regulation (IVDR). The statement calls on the E...
BioMed Alliance Response to consultation on the pharmaceutical strategy
The BioMed Alliance has submitted feedback for the consultation on the new Roadmap for the Pharmaceutical Strategy for Europe. In the response, we stress the need for coordinated action in a number of...
BioMed Alliance Joint Letter with EPF and ESC calling for investment to ensure MDR is implemented on time
The Biomedical Alliance in Europe released an open letter to EU Health Ministers with the European Patients Forum (EPF) and the European Society of Cardiology (ESC) on 7 June calling for urgent invest...
Manifesto on Treatment Optimisation
Together with other stakeholders, we support the EORTC Manifesto on Treatment Optimisation. The manifesto lists necessary and changes in order to enhance treatment optimisation and facilitate personal...